Basel, 24 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its COVID-19 At-Home ...
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...
This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys® IL-6 test. This test measures ...
Roche Holding received FDA acceptance of Lunsumio VELO plus Polivy for relapsed or refractory large B cell lymphoma based on ...
New Roche test targeting detection of Bundibugyo virus supports efforts to address critical need during ongoing outbreaks1 Roche's unique outbreak response capabilities enabled rapid development of ...
Roche confirmed that its cobas MPXV test, as well as the LightMix research-use-only kits, detect the latest mpox virus variants. (Roche) Roche says it's actively working with its partners to enhance ...
ZURICH (Reuters) - Rapid COVID-19 tests that have become a key part of nations' COVID-19 detection strategies will grow less effective as more people get vaccinated, Roche diagnostics chief Thomas ...
Roche is adding to its diagnostic capabilities through a deal to acquire GenMark Diagnostics, a molecular diagnostics company whose technology tests for multiple pathogens—including the novel ...
SHANGHAI, Jan 14 (Reuters) - BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to easier-to-use diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results